Kirschmeier P T, Housey G M, Johnson M D, Perkins A S, Weinstein I B
Cancer Center/Institute of Cancer Research, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
DNA. 1988 Apr;7(3):219-25. doi: 10.1089/dna.1988.7.219.
We describe the construction and properties of a retroviral expression vector, designated pMV-7, designed to transfer unselected cDNAs and produce their encoded proteins in recipient cells. The vector is flanked by the long terminal repeats (LTRs) of the Moloney murine sarcoma virus (MSV) and contains the selectable drug resistance gene neo under the regulation of the herpes simplex virus (HSV) thymidine kinase (tk) promoter. Unique Eco RI and Hind III sites facilitate the introduction of sequences whose transcription is regulated by the 5' LTR. We have inserted cDNAs encoding: (i) the human lymphocyte antigen T4, (ii) the human lymphocyte antigen T8, and (iii) the murine hypoxanthine-guanine phosphoribosyl transferase (HPRT), into the pMV-7 vector. These constructions were used to transduce recipient cells to the neo+ phenotype. In each case, functional assays demonstrated that 65-92% of the neo+ clones produced the appropriate protein encoded by its corresponding cDNA. These clones were characterized further by analyzing the expression of vector-regulated transcripts. The neo+T4+ clones expressed a single full-length LTR-to-LTR transcript as detected by a T4 probe. The neo+T8+ clones, however, expressed both a full-length LTR-to-LTR transcript and an additional smaller transcript as detected by a T8 probe. This smaller transcript probably resulted from the utilization of cryptic signals which control 3' RNA processing. Furthermore, all of the neo+ clones expressed a transcript that initiated from the tk promoter, contained the neo gene, and used polyadenylation signals provided by the 3' LTR. Thus, the pMV-7 vector is capable of high-efficiency transfer and high-frequency expression of the cDNA-encoded protein.
我们描述了一种逆转录病毒表达载体pMV - 7的构建及其特性。该载体旨在转移未经筛选的cDNA并在受体细胞中产生其编码的蛋白质。载体两侧是莫洛尼鼠肉瘤病毒(MSV)的长末端重复序列(LTR),并包含在单纯疱疹病毒(HSV)胸苷激酶(tk)启动子调控下的可选择药物抗性基因neo。独特的Eco RI和Hind III位点便于引入其转录受5' LTR调控的序列。我们已将编码以下内容的cDNA插入pMV - 7载体:(i)人类淋巴细胞抗原T4,(ii)人类淋巴细胞抗原T8,以及(iii)小鼠次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(HPRT)。这些构建体用于将受体细胞转导为neo +表型。在每种情况下,功能测定表明65 - 92%的neo +克隆产生了由其相应cDNA编码的适当蛋白质。通过分析载体调控转录本的表达对这些克隆进行了进一步表征。用T4探针检测,neo + T4 +克隆表达单一的全长LTR到LTR转录本。然而,用T8探针检测,neo + T8 +克隆既表达全长LTR到LTR转录本,也表达另一种较小的转录本。这种较小的转录本可能是由于控制3' RNA加工的隐蔽信号的利用所致。此外,所有neo +克隆均表达一种从tk启动子起始、包含neo基因并使用3' LTR提供的聚腺苷酸化信号的转录本。因此,pMV - 7载体能够高效转移并高频表达cDNA编码的蛋白质。